73 related articles for article (PubMed ID: 3315990)
21. [Detection of minimal disease in bone marrow from non-Hodgkin's lymphoma and its clinical significance].
Zhang W; Zhu P; Yu S
Zhonghua Yi Xue Za Zhi; 1996 Mar; 76(3):207-10. PubMed ID: 8758431
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow biopsy in non-Hodgkin's lymphoma.
Soman CS; Abraham EK
Indian J Cancer; 1988 Dec; 25(4):218-29. PubMed ID: 3243570
[No Abstract] [Full Text] [Related]
23. Bone marrow involvement in lymphoblastic lymphoma and small non-cleaved cell lymphoma: the role of trephine biopsy.
Subirà M; Domingo A; Santamaría A; Bordes R; Romagosa V; Soler J
Haematologica; 1997; 82(5):594-5. PubMed ID: 9407729
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietic activities in acute leukemia and in malignant lymphoma with or without bone marrow involvement.
Choi JW; Pai SH
Ann Clin Lab Sci; 2003; 33(4):407-10. PubMed ID: 14584754
[TBL] [Abstract][Full Text] [Related]
25. Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis.
Bregni M; Borrello MG; Siena S; Orazi A; Biassoni D; Bonadonna G; Gianni AM
Haematologica; 1989; 74(4):397-400. PubMed ID: 2507414
[TBL] [Abstract][Full Text] [Related]
26. [Clinical evaluation of bone marrow fibrosis in non-Hodgkin's lymphomas].
Ishibashi M; Hisano S; Kimura N; Morioka E; Suzumiya J; Kawara T; Nakashima H; Uchida T; Okumura M; Kikuchi M
Rinsho Ketsueki; 1992 Mar; 33(3):297-302. PubMed ID: 1578632
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow involvement and the prognosis of low grade non-Hodgkin's lymphoma.
Zemunik T; Vucković J; Marinković M; Forempoher G
Croat Med J; 1998 Dec; 39(4):419-21. PubMed ID: 9841943
[TBL] [Abstract][Full Text] [Related]
28. [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].
Li QC; Yuan XL; Wang YF; Zou DH; Zhao YZ; Qiu LG
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):254-7. PubMed ID: 18361837
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL).
Perea G; Altés A; Bellido M; Aventín A; Bordes R; Ayats R; Remacha AF; Espinosa I; Briones J; Sierra J; Nomdedéu JF
Histopathology; 2004 Sep; 45(3):268-74. PubMed ID: 15330805
[TBL] [Abstract][Full Text] [Related]
31. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome of low-grade NHL patients with bone marrow involvement.
Gronich N; Radnay J; Shapiro H; Manor Y; Lahav M; Lishner M
Eur J Clin Invest; 2007 Apr; 37(4):305-9. PubMed ID: 17373966
[TBL] [Abstract][Full Text] [Related]
33. Incidence of 'dry tap' on bone marrow aspirations in lymphomas and carcinomas. Diagnostic value of the small material in the needle.
Engeset A; Nesheim A; Sokolowski J
Scand J Haematol; 1979 May; 22(5):417-22. PubMed ID: 382344
[TBL] [Abstract][Full Text] [Related]
34. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
35. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
36. The problem of purging for ABMT in non-Hodgkin's lymphoma.
Rizzoli V; Carlo-Stella C; Almici C; Caramatti C; Mangoni L
Leukemia; 1991; 5 Suppl 1():63-7. PubMed ID: 1890869
[No Abstract] [Full Text] [Related]
37. [Cellular composition of the bone marrow and peripheral blood in patients with malignant non-Hodgkin's disease of the gastrointestinal tract].
Iatsenko SK
Vopr Onkol; 2006; 52(2):209-11. PubMed ID: 17195652
[No Abstract] [Full Text] [Related]
38. Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement.
Zenkov AN; Scvortsova NV; Chernolovskaya EL; Pospelova TI; Vlassov VV
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):843-7. PubMed ID: 15560070
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow involvement in non-Hodgkin's lymphoma in Zimbabwe.
Adewuyi B; Coutts A; Levy L; Klein S; Muronda C
East Afr Med J; 1994 Dec; 71(12):773-5. PubMed ID: 7705245
[TBL] [Abstract][Full Text] [Related]
40. [Sudden leukemization in a patient with a non-Hodgkin's lymphoma of a low grade of malignancy].
Jiménez C; Juncá J; Millá F; Ribera JM; Feliu E
Sangre (Barc); 1992 Oct; 37(5):417-8. PubMed ID: 1293791
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
